Paul Kinsella
Overview
Explore the profile of Paul Kinsella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kinsella P, Moso M, Martin G, Karapangiotidis T, Karamalakis D, Nicholson S, et al.
J Clin Virol
. 2023 Sep;
168:105580.
PMID: 37717487
The unexpected recent emergence of Japanese encephalitis virus (JEV) genotype IV in multiple southern states of Australia necessitated an evaluation of JEV serological tests suitable for diagnosing acute infection and...
2.
Lee W, Tan H, Reynaldi A, Esterbauer R, Koutsakos M, Nguyen J, et al.
Sci Adv
. 2023 Jul;
9(29):eadg5301.
PMID: 37478181
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection of vaccinated individuals is increasingly common with the circulation of highly immune evasive and transmissible Omicron variants. Here, we report the...
3.
Martin G, Tran T, Papadakis G, Kinsella P, Druce J, Caly L, et al.
Pathology
. 2023 May;
55(6):869-870.
PMID: 37147245
No abstract available.
4.
Koutsakos M, Reynaldi A, Lee W, Nguyen J, Amarasena T, Taiaroa G, et al.
Immunity
. 2023 Mar;
56(4):879-892.e4.
PMID: 36958334
Although the protective role of neutralizing antibodies against COVID-19 is well established, questions remain about the relative importance of cellular immunity. Using 6 pMHC multimers in a cohort with early...
5.
Jenney A, Chibo D, Batty M, Druce J, Melvin R, Stewardson A, et al.
Lancet Reg Health West Pac
. 2022 Jul;
26:100533.
PMID: 35821908
Background: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared...
6.
Koutsakos M, Lee W, Reynaldi A, Tan H, Gare G, Kinsella P, et al.
Immunity
. 2022 Jun;
55(7):1316-1326.e4.
PMID: 35690062
Vaccination against SARS-CoV-2 protects from infection and improves clinical outcomes in breakthrough infections, likely reflecting residual vaccine-elicited immunity and recall of immunological memory. Here, we define the early kinetics of...
7.
Higgs C, Sherry N, Seemann T, Horan K, Walpola H, Kinsella P, et al.
Nat Commun
. 2022 Jan;
13(1):509.
PMID: 35082278
Vancomycin-resistant Enterococcus faecium (VREfm) is a major nosocomial pathogen. Identifying VREfm transmission dynamics permits targeted interventions, and while genomics is increasingly being utilised, methods are not yet standardised or optimised...
8.
Williams E, Kinsella P, Kahn J, Testro A, Jones E, Jackett L, et al.
Clin Infect Dis
. 2021 Nov;
73(10):940-943.
PMID: 34791121
No abstract available.
9.
Sha J, Worsnop C, Leaver B, Vagias C, Kinsella P, Rahman M, et al.
Intern Med J
. 2019 Jun;
50(4):453-459.
PMID: 31157943
Background: Optimal management of exacerbations of chronic obstructive pulmonary disease (COPD) reduces patient morbidity and healthcare system burden. COPD guidelines, including the Global Initiative for Chronic Obstructive Lung Disease (GOLD)...
10.
Kinsella P, Shields L, McCavana P, McClean B, Langan B
J Appl Clin Med Phys
. 2016 Jul;
17(4):37-47.
PMID: 27455495
Multileaf collimators (MLCs) need to be characterized accurately in treatment planning systems to facilitate accurate intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT). The aim of this study was...